알레르기 비염 환자에 대한 압봉치료의 임상효과 연구-증상과 삶의 질을 중심으로
Objectives : The purpose of this study is to evaluate the clinical effect of Moxa-Pellet treatment for nasal symptoms and quality of life(QOL) in patients with allergic rhinitis. Methods : Subjects were voluntarily recruited through newspaper and internet advertisement. In this randomized, single bl...
Saved in:
Published in | Journal of acupuncture research pp. 175 - 185 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | Korean |
Published |
대한침구의학회
01.06.2007
|
Subjects | |
Online Access | Get full text |
ISSN | 2586-288X 2586-2898 |
Cover
Summary: | Objectives : The purpose of this study is to evaluate the clinical effect of Moxa-Pellet treatment for nasal symptoms and quality of life(QOL) in patients with allergic rhinitis.
Methods : Subjects were voluntarily recruited through newspaper and internet advertisement. In this randomized, single blind and controlled study, experimental group (n=19) received real Moxa-Pellet treatment and control group(n=20) received sham Moxa-Pellet treatment for 3 weeks. Acupuncture points used were LI4, ST36, LU7, GV14 and GB20. Patient's nasal symptoms and QOL were assessed before and after 3 weeks treatment by the Nasal Symptom Scores(NSS) and the Medical Outcomes Study 36-Item Short-Form Health Survey(SF-36).
Results : The results were as follows;
1. Among items of NSS, Sneezing․ Rhinorrhea․ Itching scores and Total Nasal Symptom Scores(TNSS) were significantly improved in experimental group after 3 weeks Moxa- Pellet treatment(p<0.05). In control group, there was no significant difference in all items except Headache item of NSS.
2. Among 8 domains of SF-36, experimental group showed significant difference in Role-Emotional(RE), Mental Health(MH) and Bodily Pain(BP) after 3 weeks Moxa- Pellet treatment(p<0.05). Control group showed no significant difference in all domains except one domain(Role limitation-physical).
Conclusions : These results suggest that Moxa-Pellet treatment can be applicable to improve nasal symptoms and QOL in the patients with allergic rhinitis. Further long term studies on the Moxa-Pellets treatment's sustaining power and safety is needed. KCI Citation Count: 14 |
---|---|
Bibliography: | G704-000258.2007.24.3.003 |
ISSN: | 2586-288X 2586-2898 |